Small molecule therapeutics for brain disorders

脑部疾病的小分子疗法

• 批准号: nhmrc : GNT1154692
• 负责人: Prof Michael Kassiou
• 金额: $ 78.54万
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/small-molecule-therapeutics-brain-disorders/1349153
• 关键词: Small; molecule; therapeutics; brain; disorders

I will establish and advance the field of CNS drug discovery in Australia. I will train the next generation of researchers and research leaders with the breadth of skills to enable efficient and cost-effective drug discovery. I will deliver new drug candidates for CNS diseases by coordinating a greater part of the drug development pathway. I will lead research translation through multidisciplinary collaboration and to focus on interrelated features that are central to CNS diseases.

我将在澳大利亚建立并推进中枢神经系统药物发现领域。我将培训下一代研究人员和研究领导者，使他们具备广泛的技能，以实现高效且具有成本效益的药物发现。我将通过协调药物开发途径的大部分来提供中枢神经系统疾病的新候选药物。我将通过多学科合作领导研究转化，并重点关注中枢神经系统疾病的核心相互关联的特征。